Seneca Biopharma Profit Margin

Seneca Biopharma (SNCA) currently reports a profit margin of -95479.92% as of December 2020. That compares with -2153.9% in the prior-year period — down 4332.9% year over year. That is below the Healthcare sector average of 14.41%. Use the charts on this page to explore Seneca Biopharma's profit margin history and peer comparisons.

Seneca Biopharma's profit margin decreased from -2153.9% to -95479.92% — a 4332.9% year-over-year decrease (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Seneca Biopharma's profit margin of -95479.92% is lower than the Healthcare sector average of 14.41%. That is roughly 662475.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Seneca Biopharma's current -95479.92% should be judged against Healthcare norms (sector average: 14.41%) and against SNCA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -95479.92%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.41%. From there, open related valuation or income-statement pages for Seneca Biopharma, and consider following SNCA for alerts when major investors trade the stock.